SCHEMBL11296050

SCHEMBL11296050

O=C(NO)c1ccc(N(C2CCNC2)S(=O)(=O)c2ccc(-c3ccccc3)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 2/20 0.48
▸ PTGES O14684 3/20 0.44
▸ ALOX5 P09917 2/20 0.44
▸ ESR1 P03372 1/20 0.44
▸ HDAC6 Q9UBN7 3/20 0.43
▸ HDAC8 Q9BY41 3/20 0.43
▸ HDAC3 O15379 2/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ ALOX12 P18054 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ NR1H3 Q13133 1/20 0.42
▸ HDAC1 Q13547 2/20 0.40
▸ SLC6A2 P23975 5/20 0.39
▸ SLC6A4 P31645 5/20 0.39
▸ CYP2D6 P10635 3/20 0.39
▸ SLC6A3 Q01959 3/20 0.39
▸ NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11028767 0.94 NR1H3 (0.47) MCL1ESR1HDAC6HDAC8HDAC3
SCHEMBL11299418 0.87 HDAC8 (0.44) HDAC6HDAC8HDAC3MAPTHDAC11
SCHEMBL11305637 0.87 HDAC6 (0.57) ESR1HDAC6HDAC8HDAC3MEN1
SCHEMBL11306334 0.77 HDAC1 (0.45) HDAC6HDAC8HDAC3MEN1KMT2A
SCHEMBL11302583 0.74 SLC6A2 (0.53) HDAC6HDAC8HDAC3MEN1KMT2A
SCHEMBL11300778 0.72 HDAC1 (0.49) HDAC6HDAC8HDAC3HDAC1SLC6A2
Hydrochloric Acid SCHEMBL9785714 0.70 ESR1 (0.58) MCL1ESR1MEN1KMT2AKDM4E
SCHEMBL11301824 0.70 KDM4E (0.39) HDAC6HDAC8MEN1KMT2AKDM4E
SCHEMBL11300763 0.69 HDAC8 (0.42) HDAC8MEN1KMT2AKDM4EALOX12
SCHEMBL11298741 0.68 SLC6A4 (0.45) SLC6A2SLC6A4CYP2D6SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback